{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:40:02Z","timestamp":1648744802006},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Historically, meningococcal disease has had a devastating impact on U.S. military personnel, but since the introduction of a vaccine in the 1970s, rates have dropped over 90%.1 Department of Defense instructions mandate a meningococcal vaccine for all service personnel. In the last 5 years, rates of meningococcal disease in the military are similar to the U.S. general population. The active duty incidence was 0.21 cases per 100,000 person-years from 2013\u20132017. Six cases occurred in the 6 months between September 2016 and February 2017; of these, only one was determined to be a vaccine-covered strain. Ongoing surveillance shows vaccination has resulted in a dramatic reduction in meningococcal cases in the military; however, it also demonstrates cases continue to occur sporadically. The recent emergence of new cases reminds us that surveillance and accompanying research are important for evaluating changes in the disease and informing new vaccine development and policy.<\/jats:p>","DOI":"10.1093\/milmed\/usy290","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T16:00:27Z","timestamp":1553270427000},"page":"102-105","source":"Crossref","is-referenced-by-count":0,"title":["Naval Health Research Center Surveillance for Meningococcal Disease"],"prefix":"10.1093","volume":"184","author":[{"given":"Michael","family":"Broderick","sequence":"first","affiliation":[{"name":"The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 140 Sylvester Road, San Diego, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Myers","sequence":"additional","affiliation":[{"name":"Operational Infectious Diseases Department, Naval Health Research Center, 140 Sylvester Road, San Diego, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"2019122604575053400_usy290C1","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"2019122604575053400_usy290C2","first-page":"5","volume-title":"Evolution of Meningococcal Disease","author":"Brundage","year":"1987"},{"key":"2019122604575053400_usy290C3","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3201\/eid1809.120257","article-title":"Trends in meningococcal disease in the United States military, 1971-2010","volume":"18","author":"Broderick","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"2019122604575053400_usy290C4","author":"Centers for Disease Control","year":"2017"},{"key":"2019122604575053400_usy290C5","author":"Centers for Disease Control","year":"2017"},{"key":"2019122604575053400_usy290C6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1086\/344273","article-title":"Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998","volume":"35","author":"Brundage","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2019122604575053400_usy290C7","author":"Naval Health Research Center","year":"2017"},{"key":"2019122604575053400_usy290C8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3201\/eid2102.141037","article-title":"Meningococcal disease in US Military personnel before and after adoption of conjugate vaccine","volume":"21","author":"Broderick","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2019122604575053400_usy290C9","author":"Centers for Disease Control","year":"2017"},{"key":"2019122604575053400_usy290C10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"2019122604575053400_usy290C11","first-page":"335","article-title":"Vaccination against meningococcal meningitis","volume":"34","author":"Goldschneider","year":"1970","journal-title":"Conn Med"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/184\/Supplement_1\/102\/31616306\/usy290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/184\/Supplement_1\/102\/31616306\/usy290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T09:58:55Z","timestamp":1577354335000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/184\/Supplement_1\/102\/5418673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":11,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2019,3,21]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usy290","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2019,3,1]]}}}